2 results
Approved WMORecruiting
To attenuate the impact and duration of delayed graft funtion by dampening schemia reperfusion injury
Approved WMOCompleted
Primary Study Objective: The primary objective of this study is to assess the efficacy of laquinimod 0.5 mg and 1.0 mg qd in patients with HD after 12 months of treatment using the UHDRS-TMS.Secondary Study Objectives:• To assess the effect of…